Dual‐Locking Nanoparticles Disrupt the PD‐1/PD‐L1 Pathway for Efficient Cancer Immunotherapy
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Dual‐Locking Nanoparticles Disrupt the PD‐1/PD‐L1 Pathway for Efficient Cancer Immunotherapy
Authors
Keywords
-
Journal
ADVANCED MATERIALS
Volume 31, Issue 51, Pages 1905751
Publisher
Wiley
Online
2019-11-11
DOI
10.1002/adma.201905751
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Microenvironment-Induced In Situ Self-Assembly of Polymer-Peptide Conjugates That Attack Solid Tumors Deeply
- (2019) Yong Cong et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Suppression of Exosomal PD-L1 Induces Systemic Anti-tumor Immunity and Memory
- (2019) Mauro Poggio et al. CELL
- Recent Advances on Reactive Oxygen Species-Responsive Delivery and Diagnosis System
- (2019) Huan Ye et al. BIOMACROMOLECULES
- The CRISPR‐Cas13a Gene‐Editing System Induces Collateral Cleavage of RNA in Glioma Cells
- (2019) Qixue Wang et al. Advanced Science
- pH-responsive gold nanoclusters-based nanoprobes for lung cancer targeted near-infrared fluorescence imaging and chemo-photodynamic therapy
- (2018) Fangfang Xia et al. Acta Biomaterialia
- Size/Charge Changeable Acidity-Responsive Micelleplex for Photodynamic-Improved PD-L1 Immunotherapy with Enhanced Tumor Penetration
- (2018) Liangliang Dai et al. ADVANCED FUNCTIONAL MATERIALS
- A Dual Immunotherapy Nanoparticle Improves T-Cell Activation and Cancer Immunotherapy
- (2018) Yu Mi et al. ADVANCED MATERIALS
- PD-1 Blockade Cellular Vesicles for Cancer Immunotherapy
- (2018) Xudong Zhang et al. ADVANCED MATERIALS
- Regulation and Function of the PD-L1 Checkpoint
- (2018) Chong Sun et al. IMMUNITY
- Cancer-Cell-Intrinsic Mechanisms Shaping the Tumor Immune Landscape
- (2018) Max D. Wellenstein et al. IMMUNITY
- PD-L1 on host cells is essential for PD-L1 blockade–mediated tumor regression
- (2018) Haidong Tang et al. JOURNAL OF CLINICAL INVESTIGATION
- Engineering PD-1-Presenting Platelets for Cancer Immunotherapy
- (2018) Xudong Zhang et al. NANO LETTERS
- In situ sprayed bioresponsive immunotherapeutic gel for post-surgical cancer treatment
- (2018) Qian Chen et al. Nature Nanotechnology
- Biochemical Aspects of PD-L1 Regulation in Cancer Immunotherapy
- (2018) Jinfang Zhang et al. TRENDS IN BIOCHEMICAL SCIENCES
- Multistage Delivery Nanoparticle Facilitates Efficient CRISPR/dCas9 Activation and Tumor Growth Suppression In Vivo
- (2018) Qi Liu et al. Advanced Science
- Endosomal Escape and Delivery of CRISPR/Cas9 Genome Editing Machinery Enabled by Nanoscale Zeolitic Imidazolate Framework
- (2017) Shahad K. Alsaiari et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- RNA targeting with CRISPR–Cas13
- (2017) Omar O. Abudayyeh et al. NATURE
- Guide-bound structures of an RNA-targeting A-cleaving CRISPR–Cas13a enzyme
- (2017) Gavin J Knott et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Nucleic acid detection with CRISPR-Cas13a/C2c2
- (2017) Jonathan S. Gootenberg et al. SCIENCE
- Dual-stimuli responsive and reversibly activatable theranostic nanoprobe for precision tumor-targeting and fluorescence-guided photothermal therapy
- (2017) Xu Zhao et al. Nature Communications
- Guide-bound structures of an RNA-targeting A-cleaving CRISPR–Cas13a enzyme
- (2017) Gavin J Knott et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- Two distinct RNase activities of CRISPR-C2c2 enable guide-RNA processing and RNA detection
- (2016) Alexandra East-Seletsky et al. NATURE
- The Interplay of Reactive Oxygen Species, Hypoxia, Inflammation, and Sirtuins in Cancer Initiation and Progression
- (2016) Marco Tafani et al. Oxidative Medicine and Cellular Longevity
- C2c2 is a single-component programmable RNA-guided RNA-targeting CRISPR effector
- (2016) Omar O. Abudayyeh et al. SCIENCE
- In Situ Formation of Nanofibers from Purpurin18-Peptide Conjugates and the Assembly Induced Retention Effect in Tumor Sites
- (2015) Di Zhang et al. ADVANCED MATERIALS
- A surface-adaptive nanocarrier to prolong circulation time and enhance cellular uptake
- (2015) Tangjian Cheng et al. CHEMICAL COMMUNICATIONS
- Pulmonary Codelivery of Doxorubicin and siRNA by pH-Sensitive Nanoparticles for Therapy of Metastatic Lung Cancer
- (2015) Caina Xu et al. Small
- Selective antigen-specific CD4+T-cell, but not CD8+T- or B-cell, tolerance corrupts cancer immunotherapy
- (2014) Adam E. Snook et al. EUROPEAN JOURNAL OF IMMUNOLOGY
- Localized Immunotherapy via Liposome-Anchored Anti-CD137 + IL-2 Prevents Lethal Toxicity and Elicits Local and Systemic Antitumor Immunity
- (2013) B. Kwong et al. CANCER RESEARCH
- Dual thermoresponsive and pH-responsive self-assembled micellar nanogel for anticancer drug delivery
- (2013) Daquan Chen et al. DRUG DELIVERY
- Mechanisms and insights into drug resistance in cancer
- (2013) Hiba Zahreddine et al. Frontiers in Pharmacology
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search